By Bill Hathaway
A drug used for cancer therapy has shown promise in reversing kidney damage caused by systemic lupus erythematosus (SLE), according to a Yale-led study (Sci Transl Med 2020;12[538]:eaay1620. doi: 10.1126/scitranslmed.aay1620).
MAY 22, 2020